What about the acquisition of a marketing and distribution company?
In an interview following the third Phase 2 result, the topic of acquisition was raised by the interviewer. I think it’s in the context of additions to the drug pipeline, but why not bolt on a sales and marketing division and retain all the value of NNZ-2591?
Timestamp: 23:30
On the Couch with Jon Pilcher: What’s Next for Neuren Pharma
A search on Grok suggests there are a few options that could be "affordable" (less than $1B). With successful Phase 3 approvals, we should be worth US$7–10B, so it could be a good investment.
- Forums
- ASX - By Stock
- NEU
- Ann: Update - Notification of buy-back - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.07%
!
$12.96

Ann: Update - Notification of buy-back - NEU, page-50
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
$13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7585 | $12.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.03 | 3344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7585 | 12.960 |
1 | 588 | 12.950 |
2 | 1799 | 12.910 |
2 | 3925 | 12.900 |
3 | 2813 | 12.890 |
Price($) | Vol. | No. |
---|---|---|
13.030 | 3344 | 2 |
13.050 | 1296 | 2 |
13.060 | 1291 | 1 |
13.070 | 2890 | 3 |
13.080 | 3090 | 3 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |